what does tirzepatide do to your brain may only temporarily quiet “food noise” Brain recordings reveal why food

Gastrointestinal symptoms, including nausea, vomiting, and diarrhea, are more commonly observed with GLP-1RAs, particularly during dose escalation [28, 29]

The best time is usually in the morning on an empty stomach or as recommended on the product label

Additionally, addressing claim 2, all GLP-1 RAs tend to have somewhere around 25% lean mass loss , so we could reasonably assume that around 9.5% of the 12.5% retatrutide figure is non-lean mass (mostly adipose tissue), with the remaining 3% being lean mass (mostly muscle)

doi:10.1016/j.exer.2006.10.008

Our data suggests that with Omadas support, patients are able to persist on their medications to achieve meaningful weight loss, which improves outcomes and protects ROI